Laurence Zitvogel, MD, PhD 

Director
Clinicobiome, Gustave Roussy Cancer Center (GRCC)

Research Director
U1015 INSERM

Scientific Co-Director
Center of Clinical Investigations Biotheris, GRCC

Full Professor,
PU-PH -University Paris Saclay

Paris, France

Prof. L. Zitvogel, MD (Clinical Oncology), PhD (Tumor Immunology), full professor at the University Paris Saclay, graduated in Medical Oncology in 1992. Scientific career first at the University of Pittsburgh, US. Became Research Director at Institut National de la Santé et Recherche Médicale U1015, and Scientific Director of the Clinicobiome program at Gustave Roussy, the largest cancer Center in Europe in 1998. Actively contributed to the field of cancer immunology and immunotherapy. Pioneer of the concepts of immunogenic cell death and gut microbiota in cancer immunosurveillance and therapies. Recipient of many awards: Translation Research INSERM Prize, the ASCO-SITC, Brupbacher Awards 2017, ESMO Immuno-Oncology Award 2017, Baillet Latour Prize 2019, the Griffuel Prize 2019, the Duquesne Ligue Prize, and ITOC9 german award. Knighted Officer of Légion d’Honneur by the French Ministry of Health 2019 and elected member of the National Academy of Medicine 2021. Her H-factor is 145, with >500 publications on PubMed, 108 265 citations in Clarivate analytics (highly cited researchers 2021, 2020, 2019, 2018, 2017, 2016).